Increased skin papilloma formation in mice lacking glutathione transferase GSTP

Cancer Research

Volumn 71, Issue 22, 2011, Pages 7048-7060

  Henderson, Colin J ^a   Ritchie, Kenneth J ^a   McLaren, Aileen ^a   Chakravarty, Probir ^b   Wolf, C Roland ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; GLUTATHIONE TRANSFERASE; LIPID; PHORBOL 13 ACETATE 12 MYRISTATE; STEROL; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER PREVENTION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HOMEOSTASIS; INTRACELLULAR SIGNALING; LIPID METABOLISM; MORPHOGENESIS; MOUSE; NONHUMAN; ONCOGENE H RAS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKIN CARCINOGENESIS; SKIN PAPILLOMA; STEROL METABOLISM; TREATMENT DURATION; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; GLUTATHIONE S-TRANSFERASE PI; MICE; OXIDATIVE STRESS; PAPILLOMA; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 81155154263     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-0882     Document Type: Article

References (51)

1. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88. (Pubitemid 40261798)
2. McIlwain CC, Townsend DM, Tew KD. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 2006;25: 1639-48.
3. Townsend DM, Tew KD. The role of glutathione-S-transferase in anticancer drug resistance. Oncogene 2003;22:7369-75.
4. Wareing CJ, Black SM, Hayes JD, Wolf CR. Increased levels of alpha-class and pi-class glutathione S-transferases in cell lines resistant to 1-chloro-2,4-dinitrobenzene. Eur J Biochem 1993; 217:671-6. (Pubitemid 23311980)
5. Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ, Wolf CR. Increased skin tumorigenesis in mice lacking pi class glutathione Stransferases. Proc Natl Acad Sci U S A 1998;95:5275-80.
6. Ritchie KJ, Henderson CJ, Wang XJ, Vassieva O, Carrie D, Farmer PB, et al. Glutathione transferase pi plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane. Cancer Res 2007;67:9248-57. (Pubitemid 47535913)
7. Ritchie KJ, Walsh S, Sansom OJ, Henderson CJ, Wolf CR. Markedly enhanced colon tumorigenesis in ApcMin mice lacking glutathione S-transferase Pi. Proc Natl Acad Sci U S A 2009;106:20859-64.
8. Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD, et al. Regulation of JNK signaling by GSTp. EMBO J 1999;18:1321-34. (Pubitemid 29110316)
9. Wu Y, Fan Y, Xue B, Luo L, Shen J, Zhang S, et al. Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 2006;25:5787-800. (Pubitemid 44435255)
10. Townsend DM, Manevich Y, He L, Hutchens S, Pazoles CJ, Tew KD. Novel role for glutathione S-transferase pi. Regulator of protein S-glutathionylation following oxidative and nitrosative stress. J Biol Chem 2009;284:436-45.
11. Gao P, Yang X, Xue YW, Zhang XF, Wang Y, Liu WJ, et al. Promoter methylation of glutathione S-transferase pi1 and multidrug resistance gene 1 in bronchioloalveolar carcinoma and its correlation with DNA methyltransferase 1 expression. Cancer 2009;115: 3222-32.
12. Yang B, House MG, Guo M, Herman JG, Clark DP. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extra-hepatic cholangiocarcinoma. Mod Pathol 2005;18:412-20. (Pubitemid 40395361)
13. Leder A, Kuo A, Cardiff RD, Sinn E, Leder P. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc Natl Acad Sci U S A 1990; 87:9178-82. (Pubitemid 120030588)
14. Spalding JW, Momma J, Elwell MR, Tennant RW. Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene. Carcinogenesis 1993;14:1335-41. (Pubitemid 23229676)
15. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3:Article 3.
16. Nishiyama H, Gill JH, Pitt E, Kennedy W, Knowles MA. Negative regulation of G(1)/S transition by the candidate bladder tumour suppressor gene DBCCR1. Oncogene 2001;20:2956-64. (Pubitemid 33027763)
17. Conklin DJ, Haberzettl P, Lesgards JF, Prough RA, Srivastava S, Bhatnagar A. Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity. J Pharmacol Exp Ther 2009;331:456-69.
18. Townsend DM, Tew KD, He L, King JB. Hanigan MH, Role of glutathione S-transferase Pi in cisplatin-induced nephrotoxicity. Biomed Pharmacother 2009;63:79-85.
19. Zhou J, Wolf CR, Henderson CJ, Cai Y, Board PG, Foster PS, et al. Glutathione transferase P1: an endogenous inhibitor of allergic responses in a mouse model of asthma. Am J Respir Crit Care Med 2008;178:1202-10.
20. Mitsushita J, Lambeth JD, Kamata T. The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation. Cancer Res 2004;64:3580-5. (Pubitemid 38657935)
21. Shinohara M, Shang WH, Kubodera M, Harada S, Mitsushita J, Kato M, et al. Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho. J Biol Chem 2007;282:17640-8. (Pubitemid 47100324)
22. Valencia A, Kochevar IE. Nox1-based NADPH oxidase is the major source of UVA-induced reactive oxygen species in human keratinocytes. J Invest Dermatol 2008;128:214-22. (Pubitemid 350249377)
23. Berhane K, Widersten M, Engstrom A, Kozarich JW, Mannervik B. Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc Natl Acad Sci U S A 1994;91:1480-4. (Pubitemid 24059036)
24. Zhou X, Yang G, Huang R, Chen X, Hu G. SVH-B interacts directly with p53 and suppresses the transcriptional activity of p53. FEBS Lett 2007;581:4943-8. (Pubitemid 47531765)
25. Huang R, Xing Z, Luan Z, Wu T, Wu X, Hu G. A specific splicing variant of SVH, a novel human armadillo repeat protein, is up-regulated in hepatocellular carcinomas. Cancer Res 2003;63:3775-82. (Pubitemid 36793066)
26. Yuasa T, Ohno S, Kehrl JH, Kyriakis JM. Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J Biol Chem 1998;273:22681-92. (Pubitemid 28399839)
27. Zhong J, Kyriakis JM. Germinal center kinase is required for optimal Jun N-terminal kinase activation by Toll-like receptor agonists and is regulated by the ubiquitin proteasome system and agonist-induced, TRAF6-dependent stabilization. Mol Cell Biol 2004;24: 9165-75. (Pubitemid 39313918)
28. Zhong J, Gavrilescu LC,Molnar A, Murray L, Garafalo S, Kehrl JH, et al. GCK is essential to systemic inflammation and pattern recognition receptor signaling to JNK and p38. Proc Natl Acad Sci U S A 2009;106:4372-7.
29. Urieli-Shoval S, Cohen P, Eisenberg S, Matzner Y. Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium. J Histochem Cytochem 1998;46:1377-84. (Pubitemid 28555406)
30. Henderson CJ, Wolf CR. Disruption of the glutathione transferase pi class genes. Methods Enzymol 2005;401:116-35. (Pubitemid 43052389)
31. Dang H, Trempus C, Malarkey DE, Wei SJ, Humble M, Morris RJ, et al. Identification of genes and gene ontology processes critical to skin papilloma development in Tg.AC transgenic mice. Mol Carcinog 2006;45:126-40. (Pubitemid 43202586)
32. Quigley DA, To MD, Perez-Losada J, Pelorosso FG, Mao JH, Nagase H, et al. Genetic architecture of mouse skin inflammation and tumour susceptibility. Nature 2009;458:505-8.
33. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjoberg J, Amir E, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010;11:76-83.
34. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad SciU S A 2005;102:15545-50. (Pubitemid 41528093)
35. Irizarry RA, Wang C, Zhou Y, Speed TP. Gene set enrichment analysis made simple. Stat Methods Med Res 2009;18:565-75.
36. Andl T, Reddy ST, Gaddapara T, Millar SE.WNTsignals are required for the initiation of hair follicle development. Dev Cell 2002;2:643-53. (Pubitemid 34538144)
37. Lo Celso C, Prowse DM, Watt FM. Transient activation of beta-catenin signalling in adult mouse epidermis is sufficient to induce new hair follicles but continuous activation is required to maintain hair follicle tumors. Development 2004;131:1787-99. (Pubitemid 38559846)
38. Huflejt ME, Leffler H. Galectin-4 in normal tissues and cancer. Glycoconj J 2004;20:247-55. (Pubitemid 39090671)
39. Umans L, Serneels L, Overbergh L, Stas L, Van Leuven F. alpha2-macroglobulin- and murinoglobulin-1- deficient mice. A mouse model for acute pancreatitis. Am J Pathol 1999;155:983-93. (Pubitemid 29426845)
40. Sutherland TE, Maizels RM, Allen JE. Chitinases and chitinase-like proteins: potential therapeutic targets for the treatment of T-helper type 2 allergies. Clin Exp Allergy 2009;39:943-55.
41. Jeronimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, et al. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2002;11:445-50. (Pubitemid 34517939)
42. Lasabova Z, Tilandyova P, Kajo K, Zubor P, Burjanivova T, Danko J, et al. Hypermethylation of the GSTP1 promoter region in breast cancer is associated with prognostic clinicopathological parameters. Neoplasma 2010;57:35-40.
43. Lozano J, Xing R, Cai Z, Jensen HL, Trempus C, Mark W, et al. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice. Cancer Res 2003;63:4232-8. (Pubitemid 36917951)
44. Murphy JE, Morales RE, Scott J, Kupper TS. IL-1 alpha, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1 alpha in epidermis on chemical carcinogenesis. J Immunol 2003;170:5697-703. (Pubitemid 36617862)
45. Robles AI, Rodriguez-Puebla ML, Glick AB, Trempus C, Hansen L, Sicinski P, et al. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev 1998;12:2469-74. (Pubitemid 28406950)
46. Larcher F, Murillas R, Bolontrade M, Conti CJ, Jorcano JL, VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene 1998;17:303-11. (Pubitemid 28383007)
47. Tober KL, Cannon RE, Spalding JW, Oberyszyn TM, Parrett ML, Rackoff AI, et al. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice. Biochem Biophys Res Commun 1998;247:644-53. (Pubitemid 28418445)
48. Banerji U, Affolter A, Judson I, Marais R, Workman P. BRAF and NRAS mutations in melanoma: potential relationships to clinical response to HSP90 inhibitors. Mol Cancer Ther 2008;7:737-9. (Pubitemid 351551026)
49. Packer LM, East P, Reis-Filho JS, Marais R. Identification of direct transcriptional targets of (V600E)BRAF/MEK signalling in melanoma. Pigment Cell Melanoma Res 2009;22:785-98.
50. Fryer AA, Ramsay HM, Lovatt TJ, Jones PW, Hawley CM, Nicol DL, et al. Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients. Carcinogenesis 2005;26:185-91. (Pubitemid 40207714)
51. Marshall SE, Bordea C, Haldar NA, Mullighan CG, Wojnarowska F, Morris PJ, et al. Glutathione S-transferase polymorphisms and skin cancer after renal transplantation. Kidney Int 2000;58: 2186-93.